The Obesity Society (TOS) is the leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity.

Compounded GLP-1 drugs are not the same as approved ones

Medications
July 22, 2026

For millions of people living with obesity, FDA-approved GLP-1 medications have created new opportunities to improve health, reduce the burden of related chronic diseases, and receive evidence-based treatment for a condition that has too often been dismissed as a matter of willpower. At the same time, extraordinary demand for these therapies has fueled the rapid growth of compounded alternatives that are often marketed as less expensive, personalized, or equivalent substitutes. …

Read more…

Compounded GLP-1 drugs are not the same as approved ones

Weight stigma in health care is a health threat

Conditions and Diseases
June 17, 2026

Words matter.

The words we use shape how we see one another, how we treat people, and how individuals see themselves. In health care, language determines whether someone feels respected or judged, supported or dismissed, empowered or ashamed. It directly influences quality of care, health outcomes, and whether a person ever returns to a health care setting. That is why the conversation surrounding obesity must change.

For decades, public discussion of obesity …

Read more…

Weight stigma in health care is a health threat